Gathering life energy

Caring for human health

OEC    Mail   |

All
  • All
  • Products
  • News
  • Introduce the content
  • Enterprise gallery

Securities code:603520


Development milestones

Zhejiang Starry Pharmaceutical Co., Ltd. was founded in 1997.

Company Incorporation

1997

Changed name to"Zhejiang starry Pharmaceutical Co., Ltd."

2003

Modern medical chemical base put into operation

2008

Jiangxi Starry Pharmaceutical Co., Ltd. was established

2011

Shanghai Starry Pharmaceutical Co., Ltd. was established

2012

Landed in the Chinese A-stock market, Stock code 603520

2016

Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd. was merged into Starry

2019

Shanghai Starry achieved commercial production of FDF

2020

Won in fifth national centralized bidding

2021

Won in seventh national centralized bidding

2022

Implement API+FDF global promotion strategy

2023-2026

Starry has been established for over 20 years

2023-2026

Implement API+FDF global promotion strategy

2022

Won in seventh national centralized bidding

2021

Won in fifth national centralized bidding

2020

Shanghai Starry achieved commercial production of FDF

2019

Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd. was merged into Starry

2016

Landed in the Chinese A-stock market, Stock code 603520

2012

Shanghai Starry Pharmaceutical Co., Ltd. was established

2011

Jiangxi Starry Pharmaceutical Co., Ltd. was established

2008

Modern medical chemical base put into operation

2003

Changed name to"Zhejiang starry Pharmaceutical Co., Ltd."

1997

Company Incorporation

Starry has been established for over 20 years

development path


2023-2026

Implement API+FDF global promotion strategy

2022

Won in seventh national centralized bidding

2021

Won in fifth national centralized bidding

2020

Shanghai Starry achieved commercial production of FDF

2019

Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd. was merged into Starry

2016

Landed in the Chinese A-stock market, Stock code 603520

2012

Shanghai Starry Pharmaceutical Co., Ltd. was established

2011

Jiangxi Starry Pharmaceutical Co., Ltd. was established

2008

Modern medical chemical base put into operation

2003

Changed name to"Zhejiang starry Pharmaceutical Co., Ltd."

1997

Company Incorporation

2023-2026

2023-2026

Implement API+FDF global promotion strategy

2022

2022

Won in seventh national centralized bidding

2021

2021

Won in fifth national centralized bidding

2020

2020

Shanghai Starry achieved commercial production of FDF

2019

2019

Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd. was merged into Starry

2016

2016

Landed in the Chinese A-stock market, Stock code 603520

2012

2012

Shanghai Starry Pharmaceutical Co., Ltd. was established

2011

2011

Jiangxi Starry Pharmaceutical Co., Ltd. was established

2008

2008

Modern medical chemical base put into operation

2003

2003

Changed name to"Zhejiang starry Pharmaceutical Co., Ltd."

1997

1997

Company Incorporation

图片名称